All Stories

  1. Re: Letter to the editor of public health in response to ‘Access to treatment with controlled medicines rationale and recommendations for neutral, respectful, and precise language’

    Article • Public Health, April 2018, Elsevier

    Dr Willem Scholten

  2. Access to treatment with controlled medicines rationale and recommendations for neutral, precise, and respectful language

    Article • Public Health, December 2017, Elsevier

    Dr Willem Scholten

  3. European drug report 2017 and opioid-induced deaths

    Article • European Journal of Hospital Pharmacy, August 2017, BMJ

    Dr Willem Scholten

  4. Opioid medicines essential in treatment of moderate and severe pain

    Article • Journal of Pain & Palliative Care Pharmacotherapy, October 2016, Taylor & Francis

    Dr Willem Scholten

  5. The unique role of transdermal buprenorphine in the global chronic pain epidemic

    Article • Acta Anaesthesiologica Taiwanica, June 2015, Elsevier

    Dr Willem Scholten

  6. Developing ‘fully evidenced’ paediatric pain guidelines

    Article • European Journal of Hospital Pharmacy, September 2013, BMJ

    Dr Willem Scholten

  7. Letter to the Editor

    Article • Journal of Pain & Palliative Care Pharmacotherapy, May 2012, Taylor & Francis

    Dr Jim Cleary, Dr Willem Scholten

  8. Providing paediatric palliative care in Kenya

    Article • The Lancet, December 2010, Elsevier

    Dr Willem Scholten

  9. Opioid Inaccessibility and Its Human Consequences: Reports From the Field

    Article • Journal of Pain & Palliative Care Pharmacotherapy, August 2010, Taylor & Francis

    Dr Willem Scholten

  10. The World Health Organization Paves the Way for Action to Free People from the Shackles of Pain

    Article • Anesthesia & Analgesia, July 2007, Wolters Kluwer Health

    Dr Willem Scholten

  11. An Interview with Willem Scholten and Myra Klee

    Article • Journal of Cannabis Therapeutics, June 2002, Taylor & Francis

    Dr Willem Scholten